BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. AAPL
6. RTB
7. ONON
8. AZN
9. SPCX
10. TRMD

Go back to BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
Bank of Commerce (NASDAQ: ONC) Delayed: 350.84 -2.62 (0.74%)
Previous Close $353.46    52 Week High $0.35 
Open $352.13    52 Week Low $0.35 
Day High $354.05    P/E N/A 
Day Low $348.76    EPS $0.00 
Volume 438,382